MedComm-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2024-10-27 ms2000001504230883 来自广西

同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？

75 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2024-11-12 COCO-么么哒来自四川省

2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受
感谢编辑和审稿人的辛勤付出

70 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2024-12-09 ms5000000789056051 来自北京

偏重的研究方向：流行病;肿瘤
经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见

32 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2024-12-25 1481ab03m35(暂无昵称) 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：癌症治疗
经验分享：总体从投到接收一共小5个月多；
一审50天，4个审稿人，外加编辑意见（大修）；
二审45天，审稿人没有意见，编辑部分意见（小修）；
三审20天，接收；
期间包含格式审查等一系列状态变化；
总体，审稿严谨，文章质量不错；
各位需要耐心等待，每个环节都是很严谨的。

145 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2025-01-13 ms4000000418941187 来自广东省

偏重的研究方向：肿瘤;基础研究
经验分享：送审容易吗这个杂志。。

20 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2025-03-04 Dr Young 来自北京

最近刚刚接收一篇，求问今年预测IF是多少？

17 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2024-06-09 red cell 来自陕西省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：基础研究
经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。

137 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2023-11-17 davenc428 来自浙江省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。

76 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2025-04-20 1483b36dm43(暂无昵称) 来自广东省

太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭

2 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2247820, encodeId=c58f224e8201e, content=偏重的研究方向：肿瘤;基础研究 经验分享：送审容易吗这个杂志。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Jan 13 00:38:14 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2254492, encodeId=50de2254492e3, content=最近刚刚接收一篇，求问今年预测IF是多少？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Tue Mar 04 07:14:59 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2169173, encodeId=4dee21691e3bb, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：多组学+功能验证，4个外审+editor一堆意见，3-4页肯定有的，一审2.5月，补了2个月的实验，再二修1月，再接受，总体审稿人还是负责任的，你说水刊目前看不至于，尤其二审有个人针对技术问题提了七八个问题，再去调原始文件给他，速度是真的不快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoxXuMyicEptPIn24A7WvH2yy9uZ2sibDK09gDPOJA2B8pB2X1jvCSXZCyS5F55dbeXiaSOqwHghdMwg/132, createdBy=b7742014545, createdName=davenc428, createdTime=Fri Nov 17 20:32:24 CST 2023, time=2023-11-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261234, encodeId=83812261234e5, content=太慢了太慢了这个杂志，快一个月了还是Awaiting AE Assignment。有一两个月才被desk reject的友友吗？😭😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca475278851, createdName=1483b36dm43(暂无昵称), createdTime=Sun Apr 20 14:23:45 CST 2025, time=2025-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258900, encodeId=8dc32258900be, content=求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aba32037768, createdName=艾彥257, createdTime=Thu Apr 03 10:08:09 CST 2025, time=2025-04-03, status=1, ipAttribution=广东省)]

2025-04-03 艾彥257 来自广东省

求问投稿之后已经4个月了，3轮pending recommendation，现在又under review，是啥情况，有战友了解吗？

16 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务